Literature DB >> 16204288

An oral load of the early glycation compound lactuloselysine fails to accumulate in the serum of uraemic patients.

Vedat Schwenger1, Christian Morath, Kathrin Schönfelder, Wolfgang Klein, Kai Weigel, Reinhold Deppisch, Thomas Henle, Eberhard Ritz, Martin Zeier.   

Abstract

BACKGROUND: It has been hypothesized that in renal failure, exogenous glycation compounds from food accumulate and play a major pathogenetic role when renal excretion is impaired.
METHODS: To address this, a diet containing a defined amount of the lysine Amadori product (AP) lactuloselysine was used. Plasma concentrations and cumulative urinary excretion of AP were assessed in 16 healthy subjects, 12 renal failure patients and 6 continuous ambulatory peitoneal dialysis (CAPD) patients. Amadori product was measured as furosine using reverse phase high performance liquid chromatography (RP-HPLC) after acid hydrolysis.
RESULTS: A diet low in glycation compounds significantly decreased excretion of APs in healthy subjects. In healthy individuals, ingestion of lactuloselysine bound to food proteins caused only a minor acute increase (8.24+/-1.11 mg/day, 2% of the administered dose) of AP excretion in the urine; in patients with renal failure not yet on dialysis, the increase in AP excretion in the urine was significantly less (4.0+/-0.51 mg/day) and the same was true in CAPD patients (0.21+/-0.09 mg/day). The plasma concentration of total APs, i.e. the sum of APs as free amino acids and residues bound to plasma proteins, did not change in any of the three groups, however.
CONCLUSION: Dietary APs do not accumulate in the blood even in advanced renal failure. The amount of APs measured as furosine excreted in the urine is significantly less, however, in renal failure and CAPD patients compared with healthy subjects. Although the findings exclude accumulation of lactuloselysine in renal failure, they do not generally exclude accumulation of other food-derived advanced glycation end products (AGEs).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204288     DOI: 10.1093/ndt/gfi151

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  3 in total

1.  Systemic activation of NF-κB driven luciferase activity in transgenic mice fed advanced glycation end products modified albumin.

Authors:  Norbert Nass; Kristina Bayreuther; Andreas Simm
Journal:  Glycoconj J       Date:  2017-02-13       Impact factor: 2.916

2.  The influence of body mass index on the accumulation of advanced glycation end products in hemodialysis patients.

Authors:  S Arsov; L Trajceska; W van Oeveren; A J Smit; P Dzekova; B Stegmayr; A Sikole; G Rakhorst; R Graaff
Journal:  Eur J Clin Nutr       Date:  2015-01-14       Impact factor: 4.016

Review 3.  Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?

Authors:  Amelia K Fotheringham; Linda A Gallo; Danielle J Borg; Josephine M Forbes
Journal:  Nutrients       Date:  2022-06-28       Impact factor: 6.706

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.